2008
DOI: 10.1016/j.pharmthera.2007.07.002
|View full text |Cite
|
Sign up to set email alerts
|

β-1 and β-2 adrenoceptor polymorphisms: Functional importance, impact on cardiovascular diseases and drug responses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

4
114
1
5

Year Published

2008
2008
2016
2016

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 119 publications
(128 citation statements)
references
References 180 publications
4
114
1
5
Order By: Relevance
“…As a consequence, an alteration of bronchodilator response to β-agonists in elderly people has been suggested [109], and also treatment with β-blockers can be more challenging due to desensitization of β-ARs and variable pharmacokinetic responses that occur with age (potentially decreased absorption, metabolism and excretion) [110]. It is clear that it is imperative to individualize therapy for each patient Finally, it must be mentioned that β1-and β2-AR responses to drug treatment exhibit marked interindividual variability [112][113][114]. At present, it seems to be clear that β-AR polymorphisms do not play a role as disease-causing genes, although they might be risk factors, might modify disease, and/or might influence progression of disease.…”
mentioning
confidence: 99%
“…As a consequence, an alteration of bronchodilator response to β-agonists in elderly people has been suggested [109], and also treatment with β-blockers can be more challenging due to desensitization of β-ARs and variable pharmacokinetic responses that occur with age (potentially decreased absorption, metabolism and excretion) [110]. It is clear that it is imperative to individualize therapy for each patient Finally, it must be mentioned that β1-and β2-AR responses to drug treatment exhibit marked interindividual variability [112][113][114]. At present, it seems to be clear that β-AR polymorphisms do not play a role as disease-causing genes, although they might be risk factors, might modify disease, and/or might influence progression of disease.…”
mentioning
confidence: 99%
“…The ADRB1 Arg389Gly polymorphism leads to the substitution of the amino acid arginine by glycine near to the intracellular carboxyl terminal, which is involved in G-protein binding. 1 The ADRA2B insertion/deletion (Ins þ 910Del (I/D)) polymorphism involves the deletion of three glutamic acids from a repeat element in the third intracellular loop of the protein.…”
mentioning
confidence: 99%
“…1 The ADRA2B deletion results in a loss of agonistpromoted desensitization. Case-control studies 1 and continuous trait analyses in patients with coronary heart disease 4 demonstrated association of the ADRB1 Arg389Gly polymorphism with hypertension 1 or with systolic 1 or diastolic 1,4 BP. However, none of these studies involved families randomly recruited from a general population.…”
mentioning
confidence: 99%
See 2 more Smart Citations